Norge - norsk - Statens legemiddelverk

2care4 generics aps - klonidinhydroklorid - tablett, drasjert - 25 mikrog

Norge - norsk - Statens legemiddelverk

orifarm generics a/s - melatonin - tablett, filmdrasjert - 2 mg

Norge - norsk - Statens legemiddelverk

2care4 generics aps - finasterid - tablett, filmdrasjert - 1 mg

Norge - norsk - Statens legemiddelverk

2care4 generics aps - flutikasonpropionat - nesespray, suspensjon - 50 mikrog/ dose

Den europeiske union - norsk - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Norge - norsk - Statens legemiddelverk

2care4 generics aps - klonidinhydroklorid - injeksjonsvæske, oppløsning - 150 mikrog/ ml

Den europeiske union - norsk - EMA (European Medicines Agency)

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Norge - norsk - Statens legemiddelverk

orifarm generics a/s - ganireliksacetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.25 mg/0.5 ml

Norge - norsk - Statens legemiddelverk

2care4 generics aps - olopatadinhydroklorid - Øyedråper, oppløsning - 1 mg/ ml

Norge - norsk - Statens legemiddelverk

orifarm generics a/s - deksklorfeniraminmaleat - tablett - 2 mg